News on Medial

Exclusive: Panacea Biotec to acquire Power Gummies

EntrackrEntrackr · 10h ago
Exclusive: Panacea Biotec to acquire Power Gummies
Medial

Exclusive: Panacea Biotec to acquire Power Gummies Pharma major Panacea Biotec Pharma Limited is set to acquire nutraceutical brand Power Gummies, according to sources aware of the matter. “The transaction is close to being finalized. Panacea Biotec will acquire the entire stake in Power Gummies, including its patents and trademarks,” said one of the sources. Regulatory filings reviewed by Entrackr show that the company is divesting certain assets to Panacea Biotec Pharma Limited, with the proceeds earmarked primarily for debt repayment. Founded in 2018, Power Gummies has positioned itself as a health and wellness brand tailored for modern lifestyles. It claims to offer unique formulations validated by WHO-standard clinical trials, backed by strong R&D and sustainable manufacturing practices. The company’s portfolio spans across categories including hair, skin, sleep, immunity, stamina, and gut health. As per sources, the deal is in the last leg and all terms and conditions have been finalised. Responding to Entrackr’s queries, Power Gummies’ founder and CEO Divij Bajaj said, “As part of the business strategic realignment process, we continuously review our portfolio. In line with this strategy, we may divest brands to a reputed pharmaceutical company to continue to build Happiness for our customers. As of now as we are still evaluating.” Queries sent to Panacea Biotec did not elicit a response until publication of the story. According to the startup data intelligence platform TheKredible, Power Gummies has raised around Rs 76.6 crore ($9 million), including its $6 million Series A funding led by 9Unicorns (now 100Unicorns). The company also raised Rs 10 crore from Jaipuria Family Office and Quadrant in December last year. For the fiscal year ending in March 2024, Power Gummies reported an operating revenue of Rs 17.4 crore against Rs 21.1 crore in FY23. Its net loss widened to Rs 21 crore from Rs 19.1 crore year-on-year. Panacea Biotec, which offloaded its domestic formulations business to Mankind Pharma in 2022 for about Rs 1,900 crore, is now eyeing growth through acquisitions. Its planned takeover of Power Gummies signals a pivot towards the nutraceutical and lifestyle wellness space, expanding beyond its traditional pharma and vaccine portfolio.

Related News

Power Gummies raises Rs 10 Cr led by Jaipuria Family Office and Quadrant

EntrackrEntrackr · 8m ago
Power Gummies raises Rs 10 Cr led by Jaipuria Family Office and Quadrant
Medial

Power Gummies, a gummies brand, has raised Rs 10 crore in its bridge round led by the Jaipuria Family Office and Quadrant. 100unicorn, DSGCP, Wipro Consumer, Venture Catalysts, Agility, Sharrp Ventures, Dhianu Das, and NB Ventures have also participated. Earlier in January 2022, Power Gummies had raised $6 million in Series A funding led by 9Unicorns and others. The proceeds will be used to enable the brand to become completely sugar-free in its products, followed by expansion into no-added sugar products and an upgraded composition in the existing range. Founded in 2018 by founder Divij Bajaj, Power Gummies focused on offering health and wellness solutions to meet today's lifestyle. The brand claims to have unique formulations backed by World Health Organisation (WHO) standard clinical trials, creating products through robust R&D while following sustainable manufacturing practices. The New Delhi-based startup is now expanding its focus by introducing a wide range of holistic wellness products under its parent company, Aesthetic Nutrition, which will now serve as the primary brand for these offerings. The lineup includes a Hair Growth Styling Serum, an All-in-One Face Serum, a Korean Collagen Peptide beauty drink, and convenient Daily Fiber Sachets to improve digestive health. It also features tailored protein supplements and vitality products designed specifically for men and women.

Exclusive: Zetwerk to acquire majority stake in Kryfs

EntrackrEntrackr · 16d ago
Exclusive: Zetwerk to acquire majority stake in Kryfs
Medial

Exclusive: Zetwerk to acquire majority stake in Kryfs Full-stack manufacturing services platform Zetwerk has moved to acquire a majority stake in Mumbai-based Kryfs Power Components, a maker of transformer cores and electrical steel products, according to regulatory filings reviewed by Entrackr. As per the filings, Zetwerk will acquire a 51% stake in Kryfs in a stock deal. The board at Zetwerk has passed a board resolution to issue 2.56 crore preference shares worth Rs 238 crore to Kryfs’s shareholders: Saifuddin Fakhruddin Qureishi, Rauzat Saifuddin Qureishi, and Aalliyah Qureishi as part of the transaction. Importantly, it remains unclear whether the remaining 49% stake will be settled in cash or in a future transaction. Queries sent to Zetwerk remained unanswered at the time of publication. The potential acquisition comes just after the company has received Rs 600 crore from its founder-owned entity Creovate Innovation. Entrackr had exclusively reported this development. Founded in 1992, KRYFS is a transformer core maker with a capacity to process 50,000 MT of CRGO electrical steel annually. The company operates across the energy supply chain, from solar power generation to transformer manufacturing, and runs 10 plants across Dadra and Nagar Haveli, Maharashtra, Gujarat, and Madhya Pradesh. ​​Zetwerk’s acquisition aligns with its plans for a $400–500 million IPO at a targeted $5 billion valuation. Adding established, revenue-generating companies like KRYFS will strengthen its manufacturing base and sharpen its positioning ahead of the listing. According to startup data intelligence platform TheKredible, Zetwerk has raised over $800 million through a mix of equity and debt funding, including a $70 million Series F round led by Khosla Ventures in December last year, which pegged its post-money valuation at $3 billion. The development was exclusively reported by Entrackr then. While it has yet to disclose its FY25 numbers, the firm reported a 26% year-on-year increase in gross revenue to Rs 14,436 crore in FY24. Zetwerk competes with Infra.Market, OfBusiness, and Moglix. Infra.Market recently raised $150 million from Mars Growth Capital.

Download the medial app to read full posts, comements and news.